Aseptic Loosening in Total Hip Arthroplasty

Aseptic loosening is loss of mechanical fixation between implant and bone, driven by a biologic reaction to wear debris (particle disease) rather than by infection. Progressive bone resorption around the implant, osteolysis, leads to pain, migration and eventual mechanical failure.

How common. It is the most common indication for revision total hip arthroplasty in the late postoperative period, beyond 5 years, and with its associated osteolysis the single most frequent indication for revision in joint registry data. [1] It progresses over years and most often becomes symptomatic beyond 5-10 years from the primary procedure.

What polyethylene cost, and what cross-linking saved. A 10-year double-blinded RCT put numbers on the conventional bearing. [2] The conventional UHMWPE arm wore at a mean 3D rate of 0.27 mm/year, with 38% osteolysis and a 14.6% revision rate; highly cross-linked polyethylene (HXLPE) reduced these to 0.03 mm/year, 8% and 1.9%. HXLPE dramatically reduces particle generation, and that lower particle load is the principal modern defence against aseptic loosening.

Risk factors. Patient, implant and technique all contribute:

• Young, active patients - higher wear rates
• Obesity - increased joint forces
• Poor implant positioning - edge loading, impingement
• Conventional polyethylene - higher wear
• Thin cement mantles - cement fracture
• Undersized components - inadequate fixation
• Osteolysis-prone patients - genetic factors (cytokine polymorphisms, below)

Aseptic loosening is fundamentally a biologic process driven by wear particles, not a purely mechanical phenomenon. The cascade runs from the bearing to the bone.

Particle generation. Polyethylene wear is the most common source. The others:

• Metal-on-metal wear (cobalt and chromium particles)
• Ceramic particles, if a liner fractures
• Cement particles (PMMA debris)
• Corrosion products at modular junctions

Particle distribution. Particles migrate along the effective joint space and enter the periprosthetic tissues through joint fluid pumping. Size matters, and the biologically critical window is narrower than the phagocytosable one: particles up to roughly 10 microns can be taken up by a macrophage, but the range that most potently drives osteolytic cytokine release from UHMWPE debris is about 0.1 to 1.0 microns. That is sub-micron, and the fraction that dominates polyethylene wear by particle number.

Do not quote "0.1 to 10 microns" as the active range. That welds the critical band to the whole phagocytosable one, and it obscures the design paradox.

The design paradox. Reducing bulk wear volume does not automatically reduce biological activity, because making particles smaller can make each one more provocative; this is the examinable subtlety. Cobalt-chrome debris from metal-on-metal bearings is nanometre-scale (roughly 10 to 120 nm, mean about 40 nm), an order of magnitude below the critical UHMWPE size. That is one reason those bearings failed by a different mechanism, metal ion release, hypersensitivity and adverse reaction to metal debris, rather than by classical particle osteolysis.

Macrophage activation. Macrophages phagocytose the particles but cannot digest polyethylene, a frustrated phagocytosis that activates them to release cytokines, chiefly TNF-α, IL-1β, IL-6 and RANKL. T cells are involved too, an adaptive immune response.

Osteoclast recruitment. RANKL binds RANK on osteoclast precursors. Osteoprotegerin (OPG) normally inhibits RANKL; here the RANKL/OPG ratio rises, and activated osteoclasts resorb bone.

Osteolysis and the membrane. Chronic inflammation forms a periprosthetic membrane of granulation tissue, containing macrophages, giant cells and particles, which extends along the implant-bone interface. Progressive resorption creates cystic lesions.

Mechanical loosening. With bone support lost, micromotion increases and the implant migrates or subsides.

Genetic factors. Polymorphisms in cytokine genes (TNF-α, IL-1) make some patients high responders to particles. This explains the variability in osteolysis rates with similar wear.

Loosening is described by where the radiolucent lines, osteolysis or component migration occur, using two standard zone systems on the AP radiograph.

View larger

Gruen zones (femoral). The femur around the stem is divided into 7 zones: 1 to 3 down the lateral side from the greater trochanter, 4 at the stem tip, and 5 to 7 up the medial side, ending at the calcar in zone 7. Where the lucency lies tells you what it means:

• Zone 7 (calcar) lucency - calcar resorption, with a risk of subsidence
• Progressive lucency in zones 1 and 7 - suggests proximal loosening
• Progressive lucency, increasing on serial films - loosening
• Lucency more than 2mm - concerning for loosening
• Circumferential lucency, around all seven zones - definitely loose

DeLee and Charnley zones (acetabular). The acetabulum is divided into 3 zones. Zone I is superolateral, the dome over the weight-bearing region and the most critical for load transfer, so lucency there is of high concern. Zone II is central, over the medial wall, and lucency there may indicate medial migration. Zone III is inferomedial, towards the ischium, and is a less common site for initial loosening.

Lucency in all three zones means the cup is definitely loose, and progressive lucency means loosening is in process. Look also for:

• Migration - a superior or medial shift of the cup, superior migration measured from Köhler's line
• Cup tilt - a change in anteversion or retroversion
• Rotation around screws, if present

Migration and subsidence. Migration is a change in position: lateral shift, rotation or tilt. Subsidence is distal, vertical settling. The criteria grade the certainty of loosening.

A single finding from this list means definite loosening:

• Migration, a change in position of more than 5mm in 2 years
• Subsidence of more than 5mm
• Component fracture
• Cement fracture
• A complete, circumferential radiolucent line more than 2mm

These make loosening probable:

• Progressive radiolucent lines, expanding over time
• Expanding osteolysis
• Lucency over more than 50% of the interface, short of circumferential
• Lucency more than 2mm thick anywhere

These mean the component is possibly loose, and it is monitored:

• Stable thin lucent lines, under 2mm and not progressing
• Focal osteolysis that is not expanding
• Early subsidence under 2mm in the first year, then stable; in an uncemented stem this early settling may be stable

View larger

Serial films. Compare every film with the immediate postoperative radiograph, repeat annually to detect progression, measure migration and subsidence quantitatively, and document lucency zone by zone.

Paprosky classification. Used in revision planning to characterise the severity of bone loss, and each grade points to a reconstruction.

History. The onset is gradual and progressive, over years not weeks, typically more than 5-10 years after surgery in a THA that often functioned well at first. Pain is in the groin (acetabular) or the thigh (femoral), and activities become progressively harder. Start-up pain, worse after rest and improving with walking, is typical.

Aseptic or septic. The history is the first discriminator. Aseptic loosening comes on gradually over months to years, the pain is mechanical and improves with activity, and there are no systemic or constitutional symptoms such as fever, malaise or night sweats. Acute or subacute onset, persistent pain despite rest, night or rest pain, systemic symptoms and a history of wound problems all raise the suspicion of infection.

Examination. The findings and what each suggests:

Range of motion. Usually preserved unless migration is severe. Pain at end range suggests impingement, and stiffness suggests other pathology such as infection or heterotopic ossification.

Neurovascular examination. Document distal pulses and sensation, and in particular the sciatic nerve after a previous posterior approach or the femoral nerve after an anterior one.

The sequence. Expose, identifying and protecting the neurovascular structures, with a complete capsulectomy, and identify and remove previous hardware. Remove the femoral head (disassociating it if modular), the acetabular liner and component and the femoral stem, then all cement, membrane and debris. Reconstruct the acetabulum and then the femur. A trial reduction checks leg length, offset and stability through a range of motion before the capsule and soft tissues are repaired and the wound closed in layers.

Dislocation. Higher after revision than after primary THA, 5-15% against 1-3%, because of soft-tissue damage and laxity, abductor insufficiency, and poor bone stock affecting component position. Restore offset and leg length, repair the posterior soft tissues after a posterior approach, and consider a dual-mobility bearing or a constrained liner in high-risk patients.

Intraoperative fracture. Most often of the femur during stem removal, treated with cerclage cables and/or revision to a longer stem. On the acetabular side a medial wall blow-out may need a cage or column plating.

Nerve injury. The sciatic nerve is most at risk, from a posterior approach and retraction; the femoral nerve with an anterior approach. Document the preoperative examination, and avoid excessive retraction and leg lengthening.

Infection. The risk is higher in revision than in primary surgery. Debride meticulously and give antibiotic prophylaxis; local vancomycin powder is an option, though a controversial one.

Weight-bearing. The reconstruction sets the restriction:

• Uncemented femur - partial weight-bearing; an extensively coated femoral stem may allow immediate weight-bearing
• Uncemented acetabulum - partial weight-bearing for 6 weeks
• Extended trochanteric osteotomy - toe-touch for 6 weeks, then partial from 6 to 12 weeks, protected until union (usually 12 weeks)
• Bone grafting - protected weight-bearing until the graft incorporates

Hip precautions after a posterior approach. No hip flexion beyond 90 degrees, no adduction past the midline and no internal rotation, for 6-12 weeks according to surgeon preference.

Watching for complications. Signs of wound infection (erythema, drainage), symptoms of DVT or PE (leg swelling, chest pain), neurovascular status, and pain out of proportion (compartment syndrome is rare).

Long-term follow-up. Radiographs at 6 weeks, 3 months and 1 year, then annually, monitoring for loosening, wear and osteolysis, documenting stable fixation (osseointegration) and checking for heterotopic ossification.

Survivorship. Modern techniques and implants have improved revision THA outcomes substantially. Freedom from re-revision is 80-90% at 10 years in modern series and 70-80% at 15 years, and worse with severe bone loss (Paprosky IIIB/IV).

What predicts it. Patient, surgeon and implant all contribute:

• Patient - age (younger patients have a higher revision risk), activity level, BMI (obesity increases failure risk) and bone quality
• Surgery - severity of bone loss (Paprosky grade), surgeon experience with revisions, achieving stable fixation, and managing soft-tissue and abductor integrity
• Implant - extensively coated stems (better outcomes than cemented in Paprosky III), tantalum augments and cups (good outcomes in the deficient acetabulum), and constrained liners (higher dislocation rate but necessary in some)

Implant-specific series. Extensively porous-coated diaphyseal femoral stems have re-revision for aseptic femoral loosening of 3% at 20 years, and any-cause femoral re-revision of 6.4% at 20 years. [4] Trabecular-metal and titanium revision cups for severe acetabular bone loss report survivorship of 100% at 5 years and 88% at 10 years. [5]

Function. Most patients achieve pain relief, functional scores improve (Harris Hip Score, WOMAC), and patients return to low-impact activities.

This section frames aseptic loosening as a global problem, drawing on the major national joint registries as cited evidence rather than the practice of any single country.

Global epidemiology

• THA volume — and therefore the at-risk population for late loosening — is rising worldwide. Registry-based modelling has projected a 208% increase in primary THA for osteoarthritis between 2013 and 2030 in high-income settings. [3] Ageing populations and rising obesity drive similar trends across high-income registries.
• Aseptic loosening / osteolysis is the leading recorded indication for revision THA in registry data; in the National Joint Registry of England and Wales it ranks ahead of dislocation, pain and periprosthetic fracture as a cause of single-stage revision. [1]
• The dominant modifiable driver historically was conventional polyethylene wear; the shift to HXLPE has reduced osteolysis and revision substantially. [2]

Major guidelines and consensus, side by side

Registry evidence (implant survival and revision)

Independent series corroborate registry signals: extensively porous-coated diaphyseal stems show only 3% re-revision for aseptic femoral loosening at 20 years [4], and trabecular-metal/titanium revision cups achieve ~88% survivorship at 10 years in deficient acetabula. [5]

Global practice variation

• Fixation philosophy differs by region: Scandinavian registries retain a strong cemented-stem tradition with excellent long-term results, while practice in North America and Australasia favours uncemented fixation — both achieve low aseptic-loosening rates in modern data.
• Resource setting changes the toolkit: porous-metal augments, cup-cage constructs and custom triflanges [4][5] are standard in high-resource centres, whereas impaction grafting and structural allograft remain important where modular porous metal is less available.
• Diagnostic access to alpha-defensin, leukocyte esterase and extended cultures varies, but the principle — exclude infection before revising a loose THA — is universal. [6]